{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:11:38Z","timestamp":1761743498359},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T00:00:00Z","timestamp":1419379200000},"content-version":"vor","delay-in-days":875,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1111\/j.1469-0691.2011.03629.x","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T15:12:38Z","timestamp":1310137958000},"page":"756-762","source":"Crossref","is-referenced-by-count":11,"title":["Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia"],"prefix":"10.1016","volume":"18","author":[{"given":"A.","family":"Hagerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Posfay-Barbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-A.","family":"Siegrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03629.x_bib1","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"issue":"suppl 3):","key":"10.1111\/j.1469-0691.2011.03629.x_bib2","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1016\/j.vaccine.2009.06.004","article-title":"Serotype replacement in perspective","volume":"27","author":"Dagan","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/649872","article-title":"Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades","volume":"50","author":"Harboe","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/PEC.0b013e3181e15e36","article-title":"Occult pneumococcal bacteremia: a review","volume":"26","author":"Joffe","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/INF.0b013e31817bd2dc","article-title":"Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine","volume":"27","author":"Casado-Flores","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000207485.39112.bf","article-title":"Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine","volume":"25","author":"Herz","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.annemergmed.2006.10.026","article-title":"Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine","volume":"49","author":"Carstairs","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20071168","article-title":"Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies","volume":"205","author":"Giefing","year":"2008","journal-title":"J Exp Med"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib10","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.vaccine.2003.11.038","article-title":"Pneumococcals vaccines: an update on current strategies","volume":"22","author":"Bogaert","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/367701","article-title":"Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease","volume":"187","author":"Zysk","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1469-0691.2010.03389.x","article-title":"Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A","volume":"17","author":"Posfay-Barbe","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/CVI.00050-09","article-title":"Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage","volume":"16","author":"Holmlund","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/IAI.69.2.949-958.2001","article-title":"Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis","volume":"69","author":"Adamou","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib15","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/IAI.01126-07","article-title":"Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis","volume":"76","author":"Glover","year":"2008","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1574-6968.1998.tb13087.x","article-title":"Molecular characterization of PcpA: a novel choline-binding protein of Streptococcus pneumoniae","volume":"164","author":"Sanchez-Beato","year":"1998","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib17","series-title":"Statistical abstract of Israel, 1996\u20131999","article-title":"Central Bureau of Statistics","author":"Israel","year":"1998"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib18","unstructured":"Statistical Yearbook of the Negev Bedouin. Beer-Sheva, Israel: Ben-Gurion University of the Negev, 2004."},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib19","series-title":"Statistical abstract of Israel","article-title":"Central Bureau of Statistics, 1997\u20132009","author":"Israel","year":"2005"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1007439908351","article-title":"Hospitalizations for infectious diseases in Jewish and Bedouin children in southern Israel","volume":"14","author":"Levy","year":"1998","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jim.2005.10.007","article-title":"Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein","volume":"308","author":"Lofgren","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib22","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1128\/IAI.71.12.7149-7153.2003","article-title":"Pneumococcal surface protein A is expressed in vivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis","volume":"71","author":"Swiatlo","year":"2003","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib23","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1371\/journal.pmed.0020015","article-title":"Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?","volume":"2","author":"Lipsitch","year":"2005","journal-title":"PLoS Med"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0264-410X(00)00201-2","article-title":"Pneumococcal surface adhesin A antibody concentration in serum and nasopharyngeal carriage of Streptococcus pneumoniae in young African infants","volume":"19","author":"Obaro","year":"2000","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.vaccine.2004.07.033","article-title":"Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease","volume":"23","author":"Baril","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/IAI.74.2.1171-1180.2006","article-title":"Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence","volume":"74","author":"Johnston","year":"2006","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib28","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1128\/IAI.00796-08","article-title":"Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease","volume":"76","author":"Borrow","year":"2008","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/652006","article-title":"Naso-pharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy","volume":"201","author":"Dagan","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03629.x_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.vaccine.2006.07.028","article-title":"Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection","volume":"25","author":"Linder","year":"2007","journal-title":"Vaccine"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14634340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14634340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T16:23:16Z","timestamp":1543681396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14634340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1198743X14634340"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03629.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}